Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk.
Adult
Asymptomatic Diseases
B-Lymphocytes
/ immunology
BNT162 Vaccine
COVID-19
/ diagnosis
COVID-19 Vaccines
/ immunology
Disease Transmission, Infectious
Female
Health Personnel
Humans
Immunity, Humoral
Italy
RNA, Viral
/ analysis
Risk
SARS-CoV-2
/ physiology
T-Lymphocytes
/ immunology
Vaccination
Viral Load
COVID19
Sars-CoV-2 infection
immune response
immunology
vaccination
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
05
2021
accepted:
08
06
2021
entrez:
12
7
2021
pubmed:
13
7
2021
medline:
3
8
2021
Statut:
epublish
Résumé
During the COVID19 pandemic, a range of vaccines displayed high efficacy in preventing disease, severe outcomes of infection, and mortality. However, the immunological correlates of protection, the duration of immune response, the transmission risk over time from vaccinated individuals are currently under active investigation. In this brief report, we describe the case of a vaccinated Healthcare Professional infected with a variant of Sars-CoV-2, who has been extensively investigated in order to draw a complete trajectory of infection. The patient has been monitored for the whole length of infection, assessing the temporal viral load decay, the quantification of viral RNA and subgenomic mRNA, antibodies (anti Sars-CoV-2, IgA, IgG, IgM) and cell-mediated (cytokine, B- and T-cell profiles) responses. Overall, this brief report highlights the efficacy of vaccine in preventing COVID19 disease, accelerating the recovery from infection, reducing the transmission risk, although the use of precautionary measures against Sars-CoV-2 spreading still remain critical.
Identifiants
pubmed: 34249017
doi: 10.3389/fimmu.2021.708820
pmc: PMC8270685
doi:
Substances chimiques
COVID-19 Vaccines
0
RNA, Viral
0
BNT162 Vaccine
N38TVC63NU
Types de publication
Case Reports
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
708820Informations de copyright
Copyright © 2021 Strafella, Caputo, Guerrera, Termine, Fabrizio, Cascella, Picozza, Caltagirone, Rossini, Balice, Salvia, Battistini, Borsellino and Giardina.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478625
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Expert Opin Biol Ther. 2020 Aug;20(8):831-836
pubmed: 32380868
J Med Virol. 2021 Mar;93(3):1210-1211
pubmed: 32966614
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
Lancet. 2021 Apr 10;397(10282):1351-1362
pubmed: 33798499
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941